BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 9545269)

  • 1. Two efficiency elements flanking the editing site of cytidine 6666 in the apolipoprotein B mRNA support mooring-dependent editing.
    Hersberger M; Innerarity TL
    J Biol Chem; 1998 Apr; 273(16):9435-42. PubMed ID: 9545269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyperediting of multiple cytidines of apolipoprotein B mRNA by APOBEC-1 requires auxiliary protein(s) but not a mooring sequence motif.
    Yamanaka S; Poksay KS; Driscoll DM; Innerarity TL
    J Biol Chem; 1996 May; 271(19):11506-10. PubMed ID: 8626710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apolipoprotein B RNA sequence 3' of the mooring sequence and cellular sources of auxiliary factors determine the location and extent of promiscuous editing.
    Sowden MP; Eagleton MJ; Smith HC
    Nucleic Acids Res; 1998 Apr; 26(7):1644-52. PubMed ID: 9512534
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulatable liver expression of the rabbit apolipoprotein B mRNA-editing enzyme catalytic polypeptide 1 (APOBEC-1) in mice lacking endogenous APOBEC-1 leads to aberrant hyperediting.
    Hersberger M; Patarroyo-White S; Qian X; Arnold KS; Rohrer L; Balestra ME; Innerarity TL
    Biochem J; 2003 Jan; 369(Pt 2):255-62. PubMed ID: 12374571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of APOBEC-1 results in mooring sequence-dependent promiscuous RNA editing.
    Sowden M; Hamm JK; Smith HC
    J Biol Chem; 1996 Feb; 271(6):3011-7. PubMed ID: 8621694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low expression of the apolipoprotein B mRNA-editing transgene in mice reduces LDL levels but does not cause liver dysplasia or tumors.
    Qian X; Balestra ME; Yamanaka S; Borén J; Lee I; Innerarity TL
    Arterioscler Thromb Vasc Biol; 1998 Jun; 18(6):1013-20. PubMed ID: 9633945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of novel alternative splice variants of APOBEC-1 complementation factor with different capacities to support apolipoprotein B mRNA editing.
    Sowden MP; Lehmann DM; Lin X; Smith CO; Smith HC
    J Biol Chem; 2004 Jan; 279(1):197-206. PubMed ID: 14570923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene transfer of cytidine deaminase apoBEC-1 lowers lipoprotein(a) in transgenic mice and induces apolipoprotein B editing in rabbits.
    Hughes SD; Rouy D; Navaratnam N; Scott J; Rubin EM
    Hum Gene Ther; 1996 Jan; 7(1):39-49. PubMed ID: 8825867
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutagenesis of apobec-1, the catalytic subunit of the mammalian apolipoprotein B mRNA editing enzyme, reveals distinct domains that mediate cytosine nucleoside deaminase, RNA binding, and RNA editing activity.
    MacGinnitie AJ; Anant S; Davidson NO
    J Biol Chem; 1995 Jun; 270(24):14768-75. PubMed ID: 7782343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of the yeast cytidine deaminase CDD1 as an orphan C-->U RNA editase.
    Dance GS; Beemiller P; Yang Y; Mater DV; Mian IS; Smith HC
    Nucleic Acids Res; 2001 Apr; 29(8):1772-80. PubMed ID: 11292850
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Only cytidines 5' of the apolipoprotein B mRNA mooring sequence are edited.
    Backus JW; Schock D; Smith HC
    Biochim Biophys Acta; 1994 Sep; 1219(1):1-14. PubMed ID: 8086446
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specific 3' sequences flanking a minimal apolipoprotein B (apoB) mRNA editing 'cassette' are critical for efficient editing in vitro.
    Backus JW; Smith HC
    Biochim Biophys Acta; 1994 Jan; 1217(1):65-73. PubMed ID: 8286418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. APOLIPOPROTEIN B: mRNA editing, lipoprotein assembly, and presecretory degradation.
    Davidson NO; Shelness GS
    Annu Rev Nutr; 2000; 20():169-93. PubMed ID: 10940331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Three distinct RNA sequence elements are required for efficient apolipoprotein B (apoB) RNA editing in vitro.
    Backus JW; Smith HC
    Nucleic Acids Res; 1992 Nov; 20(22):6007-14. PubMed ID: 1461733
    [TBL] [Abstract][Full Text] [Related]  

  • 15. APOBEC-1 dependent cytidine to uridine editing of apolipoprotein B RNA in yeast.
    Dance GS; Sowden MP; Yang Y; Smith HC
    Nucleic Acids Res; 2000 Jan; 28(2):424-9. PubMed ID: 10606639
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An AU-rich sequence element (UUUN[A/U]U) downstream of the edited C in apolipoprotein B mRNA is a high-affinity binding site for Apobec-1: binding of Apobec-1 to this motif in the 3' untranslated region of c-myc increases mRNA stability.
    Anant S; Davidson NO
    Mol Cell Biol; 2000 Mar; 20(6):1982-92. PubMed ID: 10688645
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of cytidine to uridine editing on cytoplasmic apolipoprotein B mRNA by overexpressing APOBEC-1.
    Yang Y; Sowden MP; Smith HC
    J Biol Chem; 2000 Jul; 275(30):22663-9. PubMed ID: 10833526
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disproportionate relationship between APOBEC-1 expression and apolipoprotein B mRNA editing activity.
    Siddiqui JF; Van Mater D; Sowden MP; Smith HC
    Exp Cell Res; 1999 Oct; 252(1):154-64. PubMed ID: 10502408
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Secondary structure for the apolipoprotein B mRNA editing site. Au-binding proteins interact with a stem loop.
    Richardson N; Navaratnam N; Scott J
    J Biol Chem; 1998 Nov; 273(48):31707-17. PubMed ID: 9822632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cloning and mutagenesis of the rabbit ApoB mRNA editing protein. A zinc motif is essential for catalytic activity, and noncatalytic auxiliary factor(s) of the editing complex are widely distributed.
    Yamanaka S; Poksay KS; Balestra ME; Zeng GQ; Innerarity TL
    J Biol Chem; 1994 Aug; 269(34):21725-34. PubMed ID: 8063816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.